ALPHAPORT.AI
🇹🇼CMH4745
TWDUSD
SectorHealth CareIndustryBiotechWebsitehttps://www.cowealthholding.com
Management
李惇
CEO

Company information

Ticker
4745
Country
Taiwan
Sector
Health Care
Industry
Biotech

CMH Business Summary

Cowealth Medical Holding Co., Ltd. (CMH) is a leading healthcare distribution and hospital empowerment group in Greater China, generating revenue through the transaction-based sale of advanced medical equipment and the recurring supply of in-vitro diagnostic (IVD) reagents and consumables. The company operates through two primary business segments: Equipment Sales, which distributes high-tech systems such as the CyberKnife robotic radiosurgery and MRIdian-Linac MRI-guided radiation therapy platforms, and Reagents & Consumables, which provides centralized procurement and supply chain management for clinical laboratories. CMH further differentiates its value proposition through the "Acme Empowerment Program," a suite of AI-assisted clinical decision support systems and digital operating room platforms. Within the competitive landscape, CMH maintains a dominant market position relative to regional peers such as Excelsior Medical Co., Ltd., CHC Healthcare Group, and Universal Vision Biotechnology, leveraging its unique dual-listing status on the Taipei Exchange and Shanghai Stock Exchange to facilitate cross-strait medical resource integration. Founded in 1997, CMH is led by CEO and founder Duane Lee (Lee Dan-Ho), a veteran executive with over 20 years of experience, including tenures as General Manager of the Greater China Medical Department at Philips and leadership roles at Beckman Instruments. Chairman Joyce Wang (Wang Qiongzhi) oversees the board, bringing a background in systems integration from Unisys and significant influence as Vice President of the Association of Taiwan Investment Enterprises on the Mainland (ATIEM). The executive team is bolstered by Chief Financial Officer Shu-Hua Chen, a former CFO at Unisys Taiwan, and Deputy General Manager Kenneth Tseng. CMH’s capital structure features high insider alignment, with Lee and Wang remaining the largest individual shareholders with approximately 10.8% and 9.2% stakes respectively, alongside institutional backing from strategic entities such as BenQ BM Holding and various regional asset management funds.

Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.